5CAPRIE Steering Committee. A randomised, blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)[J]. Lancet, 1996, 348(9038):1329-1339. 被引量：1
6Love BB, Biller J, Gent M. Adverse haematological effect of ticlopidine. Prevention, recognition and management[J]. Drug Saf, 1998, 19(2): 89-98. 被引量：1
8Steinhubl SR, Tan WA, Foody JM, et al. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting EPISTE-NT investigators. Evaluation of platelet Ⅱb/Ⅲa inhibitor for stenting[J]. JAMA, 1999, 281(9): 806-810. 被引量：1
9Bennett CL, Davidson C J, Raisch DW, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention[J]. Arch Intern Med, 1999, 159(21): 2524-2528. 被引量：1
10Zusman RM, Chesebro JH, Comerota A, et al. Antiplatelet therapy in the prevention of ischemic vascular events: Literature review and evidence-based guidelines for drug selection[J]. Clin Cardiol, 1999, 22(9): 559-573. 被引量：1
